<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04767360</url>
  </required_header>
  <id_info>
    <org_study_id>BFB-FBI-001</org_study_id>
    <nct_id>NCT04767360</nct_id>
  </id_info>
  <brief_title>Effects of BIONESS in Rehabilitation of Stroke</brief_title>
  <acronym>EFES-BIO-SEP</acronym>
  <official_title>Short-term Therapeutic Effects of Functional Electrical Stimulation Device Bioness L300 on the Somatosensory Cortical Representation in the Rehabilitation of Patients After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LMU Klinikum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peter Young Neurological Clinic Medicalpark Bad Feilnbach, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>LMU Klinikum</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A four-weeks randomized clinical two-period crossover-design study will be conducted. Each&#xD;
      patient will be randomized in a two separate consecutive treatment periods (Parallel Group&#xD;
      Design). &quot;Group A&quot; will be treated with functional electrical stimulation (FES) and a second&#xD;
      &quot;Gruppe B&quot; will be treated without FES for two weeks. After this period Group A and Group B&#xD;
      will switched.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prediction of motor recovery in the upper-limb (UL) / lower-limb (LL) in patients with stroke&#xD;
      is generally based on clinical examination. However, according to former studies&#xD;
      neurophysiological measures may also have a predictive value. In the acute phase, the&#xD;
      combination of the motor score and SEPs are best predictive of outcome. Neurophysiological&#xD;
      measures alone are of limited value in predicting long term outcome. However, predictive&#xD;
      accuracy is substantially improved through the combined use of both of these measures and&#xD;
      clinical variables.&#xD;
&#xD;
      A four-weeks randomized clinical two-period crossover-design study will be conducted. Each&#xD;
      patient will be randomized in a two separate consecutive treatment periods (Parallel Group&#xD;
      Design). &quot;Group A&quot; will be treated with functional electrical stimulation (FES) and a second&#xD;
      &quot;Gruppe B&quot; will be treated without FES for two weeks. After this period Group A and Group B&#xD;
      will switched.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>clinical sequential two-period crossover-design study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SEP measurement</measure>
    <time_frame>4 weeks</time_frame>
    <description>in improving pathological latencies and / or amplitudes of somatosensory evoked potentials (SEPs)&#xD;
• N35, P40, N50 (lower limb / tibial nerve) amplitude of somatosensory evoked potential [ Time Frame: Change from baseline at 4 weeks]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor score improvement</measure>
    <time_frame>4 weeks</time_frame>
    <description>• Dorsal flexion/plantar extension of the ankle strength will be measured by Janda's classification of muscle imbalance patterns (Force produced by voluntary dorsiflexion). [ Time Frame: Change from baseline at 4 weeks]</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Open labele BIONESS-Training</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Four-week therapeutic treatment of foot drop with the electrical stimulation device Bioness L300. This treatment will be performed five times a week for at least 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioness-300</intervention_name>
    <description>Therapeutic treatment of foot drop with the electrical stimulation device Bioness L300.</description>
    <arm_group_label>Open labele BIONESS-Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults between the ages of 18 and 75&#xD;
&#xD;
          -  Inadequate ankle dorsiflexion during the swing phase of gait, resulting in inadequate&#xD;
             limb clearance&#xD;
&#xD;
          -  Medically stable for at least one week following the last episode of stroke&#xD;
&#xD;
          -  Stable medication for four weeks&#xD;
&#xD;
          -  Adequate cognitive and communication function to give informed consent, understand the&#xD;
             training instructions, use the device, and give adequate feedback&#xD;
&#xD;
          -  Ability to walk with or without an assistive device (except parallel bars) at least 10&#xD;
             meters&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Lower motor neuron injury with inadequate response to stimulation&#xD;
&#xD;
               -  History of falls greater than once a week&#xD;
&#xD;
               -  Severe cardiac disease such as myocardial infarction, congestive heart failure,&#xD;
                  or a demand pacemaker&#xD;
&#xD;
               -  Patients who have other electrical stimulation devices implemented&#xD;
&#xD;
               -  Patients with epilepsy and with autoimmune diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benedikt Schoser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Friedrich-Baur-Institute, Dep. of Neurology LMU Klinikum Munich Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Mijic</last_name>
    <phone>+49 806618</phone>
    <phone_ext>7250</phone_ext>
    <email>m.mijic@medicalpark.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Young, MD</last_name>
    <email>p.young@medicalpark.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neurological Clinic Medicalpark Bad Feilnbach</name>
      <address>
        <city>Bad Feilnbach</city>
        <state>Bavaria</state>
        <zip>83075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Mijic</last_name>
      <phone>+49806618</phone>
      <phone_ext>7250</phone_ext>
      <email>m.mijic@medicalpark.de</email>
    </contact>
    <contact_backup>
      <last_name>Peter Young, MD</last_name>
      <phone>+49806618</phone>
      <phone_ext>7250</phone_ext>
      <email>p.young@medicalpark.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.medicalpark.de</url>
    <description>homepage Medicalpark Clinics</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2021</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>LMU Klinikum</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Benedikt Schoser</investigator_full_name>
    <investigator_title>Senior consultant neurologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

